Delivery Order SPE2DB22D1106-SPE2DB25FFAM1
- Not listed
- The Defense Logistics Agency awarded a $3,689.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Entresto 24 mg-26 mg tablets (60-count supply) on July 18, 2025, with an ultimate completion date of July 21, 2025. This non-competitive delivery order was placed against AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order will be fulfilled at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Entresto 97 mg-103 mg tablets (60-count units) under a firm fixed-price contract with a ceiling value of $1,597.04. This non-set-aside award represents a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The ultimate completion date for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Entresto 49 mg-51 mg tablets (180-count supply) with a ceiling value of $51,539.65. This is a firm fixed-price delivery order with an ultimate completion date of July 21, 2025, and represents a competitively awarded contract with no set-aside designation. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters...
- The Defense Logistics Agency awarded a $27,399.96 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Entresto 49 mg-51 mg tablets (60-count) on July 22, 2025, with an ultimate completion date of July 23, 2025. This non-set-aside contract is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is...
- The Defense Logistics Agency awarded a $68,784.07 delivery order to AmerisourceBergen Drug Corp for the supply of Entresto 49 mg-51 mg tablets (180-count units) on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a direct fulfillment under the company's broader pharmaceutical supply arrangements. The place of performance is AmerisourceBergen's corporate office location...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Entresto 49 mg-51 mg tablets (180-count) valued at $3,510.76. This firm fixed-price delivery order represents a non-competitive, non-set-aside award and is scheduled for completion by July 29, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor for this pharmaceutical supply transaction, which will be fulfilled from...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $83,524.51 on July 22, 2025, for the supply of Entresto 24 mg-26 mg tablets (180-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 23, 2025. AmerisourceBergen will perform the delivery order from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a...
- The Defense Logistics Agency awarded a $14,010.67 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Entresto 24 mg-26 mg tablets (60-count units). The contract, which is not set-aside and was competitively awarded, has an ultimate completion date of July 31, 2025. AmerisourceBergen Drug Corp will fulfill this order from its corporate office location in Conshohocken, Pennsylvania, where the company serves as a major pharmaceutical distributor for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Entresto 97 mg-103 mg tablets (60-count units) with a contract value of $3,439.33. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Entresto 24 mg-26 mg tablets (60-count packaging) with a ceiling value of $5,642.09. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for ultimate completion by July 29, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFAM1Delivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $3,214.04 firm fixed price delivery order for Entresto 24 mg-26 mg tablets (60-count) on July 29, 2025, with completion scheduled for July 30, 2025. This non-set-aside contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The pharmaceutical product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement through its comprehensive IDC with DLA. This prime contract vehicle enables the company to supply a broad portfolio of pharmaceutical products and medical supplies to support military healthcare programs and other government healthcare systems worldwide, including the Defense Health Agency and U.S. Coast Guard. The current delivery order for Entresto, a cardiovascular medication, reflects the company's ongoing role in fulfilling routine pharmaceutical supply needs within the DLA Troop Support Medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 7/29/25 |